Navigation Links
SEC Closes Investigation of PharmaNet Development Group and Recommends No Action
Date:10/5/2009

PRINCETON, N.J., Oct. 5 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced that the United States Securities and Exchange Commission (SEC) has notified the Company that it has completed a two and half year investigation of the Company related to revenue recognition, earnings, company operations and related party transactions and does not intend to recommend any enforcement action by the Commission. The investigation, which is now closed, was originally initiated as an informal investigation in 2006 and became formal in March 2007.

"We are very pleased that the SEC has concluded its investigation of the Company and is recommending that no action be taken by the Commission," commented Jeffrey P. McMullen, president and CEO, PharmaNet Development Group, Inc. "This very favorable outcome now allows us to put this matter behind us."

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees and 40 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com. 

    Contact: Anne-Marie Hess
    Phone: (609) 951-6842
    E-mail: ahess@pharmanet.com

SOURCE PharmaNet Development Group, Inc.


'/>"/>
SOURCE PharmaNet Development Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. PharmAbcine Closes USD $6 Million Series A Financing
2. WaferGen Closes on Private Financings of Approx. $6.2 Million
3. Helix BioPharma Closes Private Placement
4. Alimera Sciences Closes $5 Million in Extended Series C Financing
5. Jennerex Closes $5 Million First Tranche of Series C Financing
6. Micromet Closes $80.5 Million Public Offering of Common Stock
7. PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
8. Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors
9. NewLink Genetics Corporation Closes $7.5 Million Financing
10. Pharmaxis Closes Share Purchase Plan
11. China Biologic Products Closes the $9.6 Million Private Placement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...stCall/ -- Dendreon Corporation (Nasdaq: DNDN ) t...tration (FDA) provided written acknowledgement tha...ion (BLA) for PROVENGE® (sipuleucel-T) is a c...tion Drug User Fee Act (PDUFA) date of May 1, 2010...ded BLA. Dendreon is seeking licensure for PROVEN...
(Date:11/20/2009)...ently announced that Dr. Dominique Hebrault will p...Analytical Technology (PAT) in Green Chemistry and... (PRWEB) November 20, 2009 ...nology (PAT) in Green Chemistry and Green Engineer...hnology (PAT) case studies will be presented on ho...
(Date:11/19/2009)...9 Spherix Incorporated (... diabetes therapy, and a provider of technical and...t, biotechnology and pharmaceutical companies, ann...3 million registered direct placement to instituti...tock and warrants to purchase up to 1,104,348 addi...
(Date:11/19/2009)...Aegera Therapeutics Inc. announced today the dosin...udy of AEG35156, a targeted antisense therapeutic ...ications. ,, The study, entitled "An Open-Label...r of Apoptosis (XIAP) Antisense AEG35156 Given in ...in in AML Following Failure of a Single Standard D...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...gae is a livid green giveaway of nutrient pollutio...at action in tiny particles that would turn differ...spoilage or signs of poor health in the blood. , ... have tapped the working parts of cells to clear a...eat, which signifies a new approach to technology ...
... N-Viro International Corporation,(OTC Bulletin B...ing company,that owns patented technologies to con...ative fuel products, announces its renewable biofu...elines set forth by the U.S.,Environmental Protect...gy,source that may be utilized in commercial power...
...vania and REHOVOT Israel, January 16, Rosetta Geno...y unveiled initial data relating to the company,s,...creen(TM) colon, which is,based on a simple blood ...e,company,s scientists and collaborators have iden...e potential to accurately differentiate colorectal...
Other Biology Technology:Researchers: Molecular forklifts overcome obstacle to 'smart dust' 2Researchers: Molecular forklifts overcome obstacle to 'smart dust' 3N-Viro Fuel Technology Receives Alternative Energy Status From the U.S. Environmental Protection Agency 2N-Viro Fuel Technology Receives Alternative Energy Status From the U.S. Environmental Protection Agency 3N-Viro Fuel Technology Receives Alternative Energy Status From the U.S. Environmental Protection Agency 4Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 2Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 3Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 4
(Date:11/20/2009)...ass from the production of flax shives, and genera...ant related to those which engulf fields in spring... suggested by two studies carried out by Spanish a... Renewable and Sustainable Energy Reviews . , "Th...of view, the production of bioethanol from two, as...
(Date:11/19/2009)...ghly 15,000 years ago, at the end of the last ice ...als including such iconic creatures as mammoths, ... beavers began their precipitous slide to extinct...ing a land whose diversity of large animals equale...ains then or now, an entirely novel ecosystem emer...
(Date:11/19/2009)...ng Harbor, NY A four-year, multi-institutional ef... (CSHL) scientists culminated today in publication...ience revealing in unprecedented detail the DNA s...it is commonly called by North American consumers,...he most valuable agricultural crop grown in the Un...
Breaking Biology News(10 mins):Flax and yellow flowers can produce bioethanol 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4Florida Hospital Cardiovascular Institute Completes House Wide Implementation of the LifeSync 28R 29 Wireless ECG System 47699 1Florida Hospital Cardiovascular Institute Completes House Wide Implementation of the LifeSync 28R 29 Wireless ECG System 47699 2Florida Hospital Cardiovascular Institute Completes House Wide Implementation of the LifeSync 28R 29 Wireless ECG System 47699 3Understand ARRA Spending Allocations with HIMSS Analytics 26amp 3B 238482 3B Market Intelligence 47698 1Understand ARRA Spending Allocations with HIMSS Analytics 26amp 3B 238482 3B Market Intelligence 47698 2Understand ARRA Spending Allocations with HIMSS Analytics 26amp 3B 238482 3B Market Intelligence 47698 3Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 1Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 2
...anotechnology, researchers are continually on the ... and discovery to scales much smaller than the tin... at Arizona State University, researchers are usin...g at this scale holds great potential for advancin...thought of as the molecule of life, is an ideal bu...
...at Cold Spring Harbor Laboratory have for the firs...ary glands of mice to grow even after birth. They ...these cells are distinct from those that fuel the ...s suggest a novel way that the hormone-secreting g... traumatic stress or to normal life changes like p...
...inal pigment epithelial (RPE) cells attached to ti...in can improve the symptoms of patients with moder...niversity Medical Center neurosurgeon Dr. Roy A. E...nta found the therapy Spheramine was well-tolerate...nian symptoms (tremor, rigidity, slowness of movem...
Other Biology News:Scientists make chemical cousin of DNA for use as new nanotechnology building block 2Scientists make chemical cousin of DNA for use as new nanotechnology building block 3Scientists find stem cells for the first time in the pituitary 2Scientists find stem cells for the first time in the pituitary 3Cell-based therapy shows promise in patients with Parkinson's disease 2Cell-based therapy shows promise in patients with Parkinson's disease 3
Mouse Anti-Human Actopaxin, phospho (Ser8) Monoclonal Antibody, Unconjugated, Clone J160-366 from BD Biosciences Pharmingen
Anti-gp64 Antibody, Unconjugated from Novagen
Rabbit Anti-b-Catenin, phospho (Ser675) Antibody, Unconjugated from Spring Bioscience
Rabbit Anti-Human Naked1 Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Biology Products: